BHVN

Biohaven Ltd.

Trade BHVN

About Biohaven Ltd.

Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.

CEO: Vladimir Coric
IPO Date: Sep 23, 2022

Market Data

Volume: 2.3M

Valuation

Market Cap: $1.2B

Financials

Financial statement snapshot is not available yet.

现代市场行业

AI & Compute

Semiconductors & Accelerators
Cloud & AI Platforms
Data Center & Networking

Software & Digital

Enterprise Software
Cybersecurity
DevTools & Observability
Consumer Internet & Marketplaces
Digital Advertising & Media

Healthcare

GLP-1 & Metabolic Health
Biotech & Oncology
Medical Devices & Diagnostics
Healthcare Services
Pharmaceuticals

Finance & Energy

Banks & Capital Markets
Asset Management & Exchanges
Insurance
Payments & Fintech
Digital Assets
Oil, Gas & Fuels

现代分类

AI & Compute Infrastructure
Software & Digital Platforms
Healthcare Innovation
Financial Infrastructure
Energy & Grid

细分行业

Semiconductors & Accelerators
Cloud & AI Platforms
Data Center & Networking
Enterprise Software
Cybersecurity
DevTools & Observability
Consumer Internet & Marketplaces
Digital Advertising & Media

动作类型

投资人调仓
高管交易
国会交易
股票动向

浏览

历史归档
行业
分类
顶级投资人
关注列表

历史归档行业分类顶级投资人关注列表